Generate Biomedicines, Inc. · NASDAQ:GENB
Generate Biomedicines, Inc. shareholders
As of Sep 30, 2026, 104 institutions reported holding Generate Biomedicines, Inc., 82.7% of its shares. Largest: Flagship Pioneering, LLC, Fidelity and Capital Group. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Generate Biomedicines, Inc. | Change | Filed |
|---|---|---|---|---|
| Flagship Pioneering, LLC | 62.7M | 48.5% | no change | Nov 16, 2026 |
| Fidelity | 7.19M | 5.6% | +1.96M | Nov 10, 2026 |
| Capital Group | 4.2M | 3.3% | −13,642 | Nov 12, 2026 |
| Braidwell LP | 2.96M | 2.3% | −322K | Nov 16, 2026 |
| JPMorgan | 2.65M | 2.1% | +1.25M | Nov 12, 2026 |
| Vanguard | 2.62M | 2.0% | +1.13M | Nov 13, 2026 |
| Deep Track Capital, LP | 2.51M | 1.9% | +1.17M | Nov 16, 2026 |
| ARK | 1.96M | 1.5% | +680K | Nov 13, 2026 |
| ARCH Venture Management, LLC | 1.94M | 1.5% | no change | Nov 16, 2026 |
| BlackRock | 1.83M | 1.4% | +170K | Nov 13, 2026 |